For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Pathologica LLC

USPTO Granted Patents = 13

CIPO Patents = 4

EPO Patents = 6

Forward Citations = 62

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

John McKearn (9 out of 15 patents)

Jeremy T Blitzer (9 out of 14 patents)

Kenneth G Hadlock (2 out of 12 patents)

4. Hope Lancero (2 out of 2 patents)

5. Stephanie Yu (2 out of 2 patents)

6. Hien Kim Do (2 out of 2 patents)

7. Michael S McGrath (2 out of 26 patents)

8. Tennore M Ramesh (1 out of 5 patents)

9. Sean Scott (1 out of 5 patents)

10. Laurence J Marton (1 out of 20 patents)

11. Jeremy Blitzer (1 patent)

12. Michael S Mcgrath (6 patents)

13. John Mckearn (0 patent)

14. Kenneth Hadlock (0 patent)

15. Hien Do (0 patent)

13 patents: Sort by Forward Citations

1. 10881626 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2021-01-05),

2. 10350178 - Methods and compositions for treatment of demyelinating diseases (2019-07-16),

3. 10292950 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2019-05-21),

4. 10085955 - Methods and compositions for treatment of demyelinating diseases (2018-10-02),

5. 9867794 - Regulation of osteopontin (2018-01-16),

6. 9675566 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2017-06-13),

7. 9668988 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2017-06-06),

8. 9616035 - Pharmaceutical for oral delivery comprising MGBG and methods of treating disease (2017-04-11),

9. 8858991 - Delayed release oral pharmaceutical dosage forms comprising MGBG (2014-10-14),

10. 8445540 - Regulation of osteopontin (2013-05-21),

11. 8258186 - Pharmaceutical for oral delivery comprising MGBG (2012-09-04),

12. 8198334 - Methods for modulating macrophage proliferation in ocular disease using polyamine analogs (2012-06-12),

13. 7198946 - Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis (2007-04-03),

Pathologica LLC is a leading healthcare technology company specializing in diagnostic solutions. We provide innovative pathology services integrating advanced digital imaging and artificial intelligence technologies. Our mission is to improve diagnostic accuracy, enhance patient outcomes, and streamline workflow efficiency for healthcare professionals. With our state-of-the-art platform, we empower medical experts to make faster and more accurate diagnoses, enabling more effective treatment decisions. Visit our website to learn more about our cutting-edge solutions and how we are revolutionizing pathology practices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#348 in San Francisco, CA

#5,489 in California

#23,149 in US

#43,690 in the World

San Francisco, CA, United States of America

Pathologica LLC

Forward Citations = 62

10 inventors:

John McKearn (9 out of 15 patents)

Jeremy T Blitzer (9 out of 14 patents)

Kenneth G Hadlock (2 out of 12 patents)

4. Hope Lancero (2 out of 2 patents)

5. Stephanie Yu (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…